| Hidradenitis Suppurativa |
1 |
1 |
| Skin and Soft Tissue Infection |
0 |
0.96 |
| Biologic Therapy |
0 |
0.99 |
| Abscess |
0 |
0.46 |
| Europe |
0 |
0.46 |
| Dentistry and Oral Health |
0 |
0.34 |
| Hospital |
0 |
0.31 |
| Monoclonal Antibody |
0 |
0.31 |
| Nodule |
0 |
0.31 |
| Psoriatic Arthritis |
0 |
0.28 |
| Psoriasis |
0 |
0.26 |
| Ankylosing Spondylitis |
0 |
0.15 |
| Arthritis |
0 |
0.15 |
| Clinical Research |
0 |
0.15 |
| Fistula |
0 |
0.15 |
| Interleukin |
0 |
0.15 |
| Oral Candidiasis |
0 |
0.15 |
| Pain |
0 |
0.15 |
| Plaque Psoriasis |
0 |
0.15 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.15 |
| Targeted Cancer Therapy |
0 |
0.15 |
| Tissue |
0 |
0.15 |
| Tumor |
0 |
0.15 |
| Weakness |
0 |
0.15 |
| Fungal Infection |
0 |
0.14 |
| Candidiasis |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Pain Management |
0 |
0.1 |